Smartwatches may help doctors decide when to treat AF, new trial aims to prove it
NCT ID NCT07512037
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial will enroll about 3,200 people with paroxysmal atrial fibrillation (AF) to see if using a smartwatch to continuously track AF burden can guide earlier and better treatment. Participants will be monitored with a wearable device, and if their AF burden is high, doctors will step up therapy—like adjusting medications or considering a procedure. The goal is to reduce serious events such as stroke, heart failure, and hospitalizations over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
5D-AF burden-guided active management (behavioral intervention using wearable PPG monitoring and stepwise rhythm control)
What this could lead to
If successful, this could show that continuous wearable monitoring helps doctors decide when to start or adjust treatment, potentially reducing serious AF complications like stroke and heart failure.
What could go wrong
This trial is not yet recruiting and is early-stage for this specific monitoring model. The approach may not reduce adverse events more than standard care, and results may not apply to all AF patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sixth Medical Center of Chinese PLA General Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••